WALGREEN COMPANY for WALGREEN COMPANY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
S. 2862 - "Regulatory Transparency, Patient Access and Effective Drug Enforement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.H.R. 4709 - the "Ensuring Patient Access and Effective Drug Enforcement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
Taxation/Internal Revenue Code TAX
Issues related to United States corporate tax reform - no specific legislation.S. 336 - the "Marketplace Fairness Act," all provisions regarding authorizing each state under the Streamlined Sales and Use Tax Agreement (the multistate agreement for the administration and collection of sales and use taxes adopted on November 12, 2002) to require all sellers not qualifying for a small-seller exception (applicable to sellers with annual gross receipts in total U.S. remote sales not exceeding $1 million) to collect and remit sales and use taxes.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
Medicare/Medicaid MMM
S. 557 and H.R. 1024 - the "Medication Therapy Management Empowerment Act," amending the Medicare Modernization Act to expand the eligibility for beneficiaries for access to Medication Therapy Management (MTM) in Medicare Part D.S. 867 - the "Medicare Prescription Drug Program Integrity and Transparency Act," a bill to amend Title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program, to establish basic audit standards of pharmacies, to further transparency of payment methodology to pharmacies, and to provide for recoupment returns to Medicare.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
Pharmacy PHA
H.R. 4190 - all provisions related to amending the Social Security Act to allow pharmacists to be reimbursed under Medicare Part B for services provided to patients in medically underserved communitites, consistent with state scope of practice laws.S. 621 and H.R. 1285 - the "Safe Prescribing Act of 2013," all provisions regarding amendment of the Controlled Substances Act to make any substance containing hydrocodone a Schedule II drug.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBBIE GARZA | — |
| ALETHIA JACKSON | — |
| EDWARD KALETA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.